Bimiralisib (PQR309) CAS;1225037-39-7
Bimiralisib (PQR309)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1976 | 50mg | 335.00 | + Add to cart |
|
| R-C-1976 | 100mg | 500.00 | + Add to cart |
|
| R-C-1976 | 200mg | 900.00 | + Add to cart |
|
|
|
||||
Product description
Bimiralisib(PQR309)is a potent,brain-penetrant,orally bioavailable,pan-class I PI3K/mTOR inhibitor with IC50s of 33nM,451nM,661nM,708nM and 89nM for PI3Kα,PI3Kδ,PI3Kβ,PI3Kγ and mTOR,respectively.Bimiralisib is an mTORC1 and mTORC2 inhibitor.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---Bimiralisib (PQR309)
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


